- Low
- 85,000
- Average
- 157,114
- Median
- 134,347
- High
- 307,845
Acorda Therapeutics Salary
10
30
18
Acorda Therapeutics average salary is $157,114, median salary is $134,347 with a salary range from $85,000 to $307,845.
Acorda Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Acorda Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Acorda Therapeutics salaries are collected from government agencies and companies. Each salary is associated with a real job position. Acorda Therapeutics salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Related Acorda Therapeutics Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Acorda Therapeutics salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Acorda Therapeutics Jobs
| See more Acorda Therapeutics Jobs» | |
| Search All Jobs | |
Patents information
980
All Patents
270
Grant Patents
606
Patents Pending
192
Patents Families
More Recent
-
US20240050376A1SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
-
US20240041850A1Methods of Using Sustained Release Aminopyridine Compositions
-
US12029820B2Sustained release compositions of 4-aminopyridine
- View More »
Acorda Therapeutics... Information
- Acorda Therapeutics
- Industry: BioTech/Drugs
- City: Hawthorne, NY
- Acorda Therapeutics, a privately held biotechnology company, is developing therapies for spinal cord injury (SCI) and related neurological conditions, including multiple sclerosis (MS). The Company's lead product, Fampridine-SR, is in Phase 3 clinical trials for chronic SCI and Phase 2 for MS. Acorda's technology platform includes two remyelinating agents in preclinical development for MS. They include M1, a class of human monoclonal antibodies, and GGF2, a product of the neuregulin 1 gene. Both agents have been shown to restore myelin in the brain and spinal cord in animal models of MS. Additionally, Acorda is developing multiple approaches to regeneration and
